Risk factor
Negligible price volatility
Profitability factor
Very strong margins and returns
About
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a...
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBITDA, overpri
Target Price
The average target price of DRREDDY.NS is 1209 and suggests 2% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation t
Buy
Sell